MetaSight Diagnostics

📍 Rehovot, Israel🗓 Founded 2021👥 15 employees💰 Last funded Oct 2024
Medical and Diagnostic Laboratories🌐 metasightdx.com
Website LinkedIn
MetaSight Diagnostics, a health technology company, is on a mission to create affordable and precise liquid biopsy diagnostics for early detection of a variety of chronic and acute diseases, utilizing proprietary, cost-effective mass spectrometry technologies (metabolomics, lipidomics and proteomics). The company has created the world’s largest and most comprehensive serum metabolomics dataset linked with Electronic Health Records and is pursuing additional omics. This unprecedented platform is used by MetaSight’s team of experts in analytical chemistry, AI, and medicine to develop and commercialize diagnostic products to improve human health.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Israel
1
United States
1
Frequently asked questions
Who invested in MetaSight Diagnostics?
MetaSight Diagnostics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did MetaSight Diagnostics last raise funding?
The most recent investment in MetaSight Diagnostics recorded on gritt.io was in October 2024.
When was MetaSight Diagnostics founded?
MetaSight Diagnostics was founded in 2021.
What industry is MetaSight Diagnostics in?
MetaSight Diagnostics operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is MetaSight Diagnostics based?
MetaSight Diagnostics is headquartered in Rehovot, Israel.